This HTML5 document contains 52 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n7http://localhost/temp/predkladatel/
n15http://linked.opendata.cz/resource/domain/vavai/projekt/
n10http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n8http://linked.opendata.cz/ontology/domain/vavai/
n13http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/
skoshttp://www.w3.org/2004/02/skos/core#
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n18http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n19http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216208%3A11150%2F10%3A10082901%21RIV11-MZ0-11150___/
n14http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n17http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216208%3A11150%2F10%3A10082901%21RIV11-MZ0-11150___
rdf:type
n8:Vysledek skos:Concept
dcterms:description
Aminoglycosides are bactericidal antibiotics used worldwide for the treatment of serious infections in critically ill patients, including neonates.Critically ill neonates constitute a unique challenge in dosing owing to the pathologic alterations that accompany severe illness and the rapidly changing conditions of these patients. Aminoglycosides are bactericidal antibiotics used worldwide for the treatment of serious infections in critically ill patients, including neonates.Critically ill neonates constitute a unique challenge in dosing owing to the pathologic alterations that accompany severe illness and the rapidly changing conditions of these patients.
dcterms:title
Tolerability and Outcomes of Kinetically Guided Therapy With Gentamicin in Critically Ill Neonates During the First Week of Life: An Open-Label, Prospective Study Tolerability and Outcomes of Kinetically Guided Therapy With Gentamicin in Critically Ill Neonates During the First Week of Life: An Open-Label, Prospective Study
skos:prefLabel
Tolerability and Outcomes of Kinetically Guided Therapy With Gentamicin in Critically Ill Neonates During the First Week of Life: An Open-Label, Prospective Study Tolerability and Outcomes of Kinetically Guided Therapy With Gentamicin in Critically Ill Neonates During the First Week of Life: An Open-Label, Prospective Study
skos:notation
RIV/00216208:11150/10:10082901!RIV11-MZ0-11150___
n4:aktivita
n9:Z n9:P
n4:aktivity
P(1A8671), Z(MSM0021620820)
n4:cisloPeriodika
14
n4:dodaniDat
n17:2011
n4:domaciTvurceVysledku
n10:4922417 n10:9336478 n10:1802054 n10:4804007 n10:5481546
n4:druhVysledku
n12:J
n4:duvernostUdaju
n18:S
n4:entitaPredkladatele
n19:predkladatel
n4:idSjednocenehoVysledku
293016
n4:idVysledku
RIV/00216208:11150/10:10082901
n4:jazykVysledku
n14:eng
n4:klicovaSlova
tolerability; sepsis; neonates; gentamicin; aminoglycosides
n4:klicoveSlovo
n5:aminoglycosides n5:sepsis n5:neonates n5:tolerability n5:gentamicin
n4:kodStatuVydavatele
US - Spojené státy americké
n4:kontrolniKodProRIV
[12EC9B62002C]
n4:nazevZdroje
Clinical Therapeutics
n4:obor
n16:FR
n4:pocetDomacichTvurcuVysledku
5
n4:pocetTvurcuVysledku
7
n4:projekt
n15:1A8671
n4:rokUplatneniVysledku
n17:2010
n4:svazekPeriodika
32
n4:tvurceVysledku
Chládek, Jaroslav Záhora, Jiří Vobruba, Václav Martínková, Jiřina Pokorná, Pavla Selke - Krulichová, Iva Chládková, Jiřina
n4:wos
000288640500009
n4:zamer
n13:MSM0021620820
s:issn
0149-2918
s:numberOfPages
15
n7:organizacniJednotka
11150